Original Article

You have full text access to this OnlineOpen article

Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas

  1. Simona Grozinsky-Glasberg MD1,2,†,*,
  2. Dganit Barak MRS3,
  3. Merav Fraenkel MD3,
  4. Martin A. Walter MD4,
  5. Jan Müeller-Brand MD4,
  6. Joseph Eckstein MD5,
  7. Liat Applebaum MD6,
  8. Ilan Shimon MD1,2,
  9. David J. Gross MD3

Article first published online: 8 NOV 2010

DOI: 10.1002/cncr.25646

Issue

Cancer

Cancer

Volume 117, Issue 7, pages 1377–1385, 1 April 2011

Additional Information

How to Cite

Grozinsky-Glasberg, S., Barak, D., Fraenkel, M., Walter, M. A., Müeller-Brand, J., Eckstein, J., Applebaum, L., Shimon, I. and Gross, D. J. (2011), Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas. Cancer, 117: 1377–1385. doi: 10.1002/cncr.25646

Author Information

  1. 1

    Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center, Tel Aviv, Israel

  2. 2

    Sackler Faculty of Medicine, Tel Aviv, Israel

  3. 3

    Endocrinology and Metabolism Service, Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  4. 4

    Institute of Nuclear Medicine, University Hospital, Basel, Switzerland

  5. 5

    Imaging Department, Beilinson Hospital, Rabin Medical Center, Tel Aviv, Israel

  6. 6

    Imaging Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  1. †

    Fax: (011) 972-3-9211403

*Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center, Petah Tikva, 49100 Israel

Publication History

  1. Issue published online: 18 MAR 2011
  2. Article first published online: 8 NOV 2010
  3. Manuscript Accepted: 16 AUG 2010
  4. Manuscript Revised: 30 JUL 2010
  5. Manuscript Received: 18 JUN 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS